earnings
confidence high
sentiment positive
materiality 0.85
Hims & Hers Q1 revenue $586M (+111% YoY), net income $49.5M, raises EBITDA guidance
Hims & Hers Health, Inc.
2025-Q1 EPS reported
$0.20
revenue$586,010,000
- Revenue $586M (+111% YoY); net income $49.5M (up 345% YoY); Adj. EBITDA $91.1M (up 182% YoY).
- Subscribers 2.4M (+38% YoY); monthly online rev per sub $84 (+53% YoY).
- Affirms FY2025 revenue guidance $2.3-$2.4B; raises Adj. EBITDA outlook to $295-$335M.
- Introduced 2030 targets of at least $6.5B revenue and $1.3B Adj. EBITDA.
- Gross margin 73% (down 900bps YoY) on GLP-1 mix; partnered with Novo Nordisk for Wegovy access.